Abstract
TOP-104 - The TLR8 agonist Selgantolimod modulates Kupffer cell differentiation status and indirectly impairs HBV entry into hepatocytes via an IL-6-dependent mechanism
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have